Fertility treatment and risk of breast cancer

被引:53
作者
Braga, C
Negri, E
LaVecchia, C
Parazzini, F
DalMaso, L
Franceschi, S
机构
[1] IST RIC FARMACOL MARIO NEGRI,I-20157 MILAN,ITALY
[2] UNIV MILAN,IST STAT MED & BIOMETRIA,I-20132 MILAN,ITALY
[3] UNIV MILAN,PRIMA CLIN OSTET & GINECOL,I-20129 MILAN,ITALY
[4] CTR RIFERIMENTO ONCOL,SERV EPIDEMIOL,I-33081 AVIANO,PN,ITALY
关键词
breast cancer; fertility drugs;
D O I
10.1093/HUMREP/11.2.300
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The relationship between fertility treatment and breast cancer was investigated in a multicentric case-control study conducted in Italy on 2569 women with incident, histologically confirmed breast cancer and 2588 control women admitted to hospitals for acute, non-neoplastic, non-hormonal or gynaecological conditions, unrelated to fertility problems. The odds ratio of breast cancer was 1.08 (95% confidence interval 0.8-1.5) in those reporting fertility treatment compared with those who did not receive fertility treatment. Similarly, the odds ratio was 0.60 for women with tubal occlusion, 0.99 for those reporting hormonal imbalances and 1.32 for other/unspecified reasons, There was no consistent pattern of risk according to age at treatment and time since treatment, Women reporting fertility treatment with drug use had an odds ratio of 1.43, while those who did not report drug therapy had an odds ratio of 0.85. None of these odds ratio estimates was significant. Likewise, there was no heterogeneity among strata of parity, menopausal status, education and family history of breast cancer. Thus, our study, while providing reassuring evidence on the relationship between fertility treatment and breast cancer risk, cannot exclude the possibility that the use of specific drugs may be related to breast carcinogenesis.
引用
收藏
页码:300 / 303
页数:4
相关论文
共 23 条
  • [1] BERNSTEIN L, 1995, CANCER EPIDEM BIOMAR, V4, P437
  • [2] Breslow NE, 1980, IARC SCI PUBL, V1
  • [3] CANCER RISK AFTER EVALUATION FOR INFERTILITY
    BRINTON, LA
    MELTON, LJ
    MALKASIAN, GD
    BOND, A
    HOOVER, R
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1989, 129 (04) : 712 - 722
  • [4] CASAGRANDE JT, 1979, LANCET, V2, P170
  • [5] COULAM CB, 1983, OBSTET GYNECOL, V61, P403
  • [6] BREAST-CANCER INCIDENCE IN WOMEN WITH A HISTORY OF PROGESTERONE DEFICIENCY
    COWAN, LD
    GORDIS, L
    TONASCIA, JA
    JONES, GS
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1981, 114 (02) : 209 - 217
  • [7] INFERTILITY AND BREAST-CANCER - A POPULATION-BASED CASE-CONTROL STUDY
    GAMMON, MD
    THOMPSON, WD
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1990, 132 (04) : 708 - 716
  • [8] CHARACTERISTICS RELATING TO OVARIAN-CANCER RISK - COLLABORATIVE ANALYSIS OF 12 UNITED-STATES CASE-CONTROL STUDIES .3. EPITHELIAL TUMORS OF LOW MALIGNANT POTENTIAL IN WHITE WOMEN
    HARRIS, R
    WHITTEMORE, AS
    ITNYRE, J
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1992, 136 (10) : 1204 - 1211
  • [9] HENDERSON BE, 1985, CANCER, V56, P1206, DOI 10.1002/1097-0142(19850901)56:5<1206::AID-CNCR2820560541>3.0.CO
  • [10] 2-9